These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30541498)

  • 1. Impact of engaging security personnel on access and polio immunization outcomes in security-inaccessible areas in Borno state, Nigeria.
    Nkwogu L; Shuaib F; Braka F; Mkanda P; Banda R; Korir C; Bawa S; Mele S; Saidu M; Mshelia H; Shettima A; Tegegne SG; Yehualashet YG; Adamu U; Nsubuga P; Vaz RG; Wondimagegnehu A
    BMC Public Health; 2018 Dec; 18(Suppl 4):1311. PubMed ID: 30541498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress Toward Poliomyelitis Eradication - Nigeria, January-December 2017.
    Bolu O; Nnadi C; Damisa E; Braka F; Siddique A; Archer WR; Bammeke P; Banda R; Higgins J; Edukugo A; Nganda GW; Forbi JC; Liu H; Gidado S; Soghaier M; Franka R; Waziri N; Burns CC; Vertefeuille J; Wiesen E; Adamu U
    MMWR Morb Mortal Wkly Rep; 2018 Mar; 67(8):253-256. PubMed ID: 29494568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.
    Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK
    J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding inhabited settlements and tracking vaccination progress: the application of satellite imagery analysis to guide the immunization response to confirmation of previously-undetected, ongoing endemic wild poliovirus transmission in Borno State, Nigeria.
    Higgins J; Adamu U; Adewara K; Aladeshawe A; Aregay A; Barau I; Berens A; Bolu O; Dutton N; Iduma N; Jones B; Kaplan B; Meleh S; Musa M; Wa Nganda G; Seaman V; Sud A; Vouillamoz S; Wiesen E
    Int J Health Geogr; 2019 May; 18(1):11. PubMed ID: 31096971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress toward poliomyelitis eradication - Nigeria, January 2012-September 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1009-13. PubMed ID: 24336134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas - Nigeria, 2016.
    Nnadi C; Damisa E; Esapa L; Braka F; Waziri N; Siddique A; Jorba J; Nganda GW; Ohuabunwo C; Bolu O; Wiesen E; Adamu U
    MMWR Morb Mortal Wkly Rep; 2017 Feb; 66(7):190-193. PubMed ID: 28233765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised Household-Based Microplanning in Polio Supplemental Immunization Activities in Kano State, Nigeria. 2013-2014.
    Gali E; Mkanda P; Banda R; Korir C; Bawa S; Warigon C; Abdullahi S; Abba B; Isiaka A; Yahualashet YG; Touray K; Chevez A; Tegegne SG; Nsubuga P; Etsano A; Shuaib F; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S73-8. PubMed ID: 26908755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding polio surveillance reach beyond vaccination reach in Borno State, Nigeria: The contribution of community informants from insecure areas engaged to conduct polio surveillance in security compromised areas, 2018-2019.
    Mohammed AM; Musa A; Etapelong SG; Bolori MT; Salanga DR; Ndahi D; Meleh S; Kunle I; Shettima A; Mohammed K; Siyaka SM; Manu IJ; Ilesanmi O; Adamu US; Shuaib F; Tesfaye E; Braka F; Mulombo WK
    Vaccine; 2024 Feb; 42(4):770-776. PubMed ID: 37230888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Historical reconstruction of inaccessibility status in Local Government Areas (LGAs) of Borno and Yobe States, Nigeria, 2010-2020.
    Forbi JC; Musa MS; Salawu M; Idris JM; Ba'aba AI; Higgins J; Musa AI; Bashir B; Shettima A; Njeakor N; Uzoma I; Mshelia H; Nganda GW; Mohammed KI; Bomoi IM; Chiroma U; Kovacs SD; Biya O; Waziri NE; Aina M; Adamu US; Shuaib F; Bolu O; Franka R; Wiesen E
    Pan Afr Med J; 2023; 45(Suppl 2):7. PubMed ID: 38370102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing transit polio vaccination in collaboration with targeted stakeholders in Kaduna State, Nigeria: Lessons learnt: 2014-2015.
    Musa A; Abba B; Ningi AM; Gali E; Bawa S; Manneh F; Mkanda P; Banda R; Yehuluashet YG; Tegegne SG; Umeh G; Nsubuga P; Etsano A; Shuaib F; Mohammed A; Vaz RG
    Vaccine; 2016 Oct; 34(43):5159-5163. PubMed ID: 27364095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress Toward Poliomyelitis Eradication - Nigeria, January 2018-May 2019.
    Adamu US; Archer WR; Braka F; Damisa E; Siddique A; Baig S; Higgins J; Sume GE; Banda R; Korir CK; Waziri N; Gidado S; Bammeke P; Edukugo A; Nganda GW; Forbi JC; Burns CC; Liu H; Jorba J; Asekun A; Franka R; Wassilak SGF; Bolu O
    MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(29):642-646. PubMed ID: 31344023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences from polio supplementary immunization activities in Anambra State, Nigeria.
    Onyeka IN; Ilika AL; Ilika FN; Umeh DC; Onyibe RI; Okoye CJ; Diden G; Onubogu CU
    Niger J Clin Pract; 2014; 17(6):808-13. PubMed ID: 25385924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demand Creation for Polio Vaccine in Persistently Poor-Performing Communities of Northern Nigeria: 2013-2014.
    Warigon C; Mkanda P; Muhammed A; Etsano A; Korir C; Bawa S; Gali E; Nsubuga P; Erbeto TB; Gerlong G; Banda R; Yehualashet YG; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S79-85. PubMed ID: 26908717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polio field census and vaccination of underserved populations--northern Nigeria, 2012-2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):663-5. PubMed ID: 23965829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.
    Musa A; Mkanda P; Manneh F; Korir C; Warigon C; Gali E; Banda R; Umeh G; Nsubuga P; Chevez A; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S91-5. PubMed ID: 26609003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress Toward Poliomyelitis Eradication--Nigeria, January 2014-July 2015.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Ticha JM; Banda R; Korir C; Chevez AE; Enemaku O; Corkum M; Davis LB; Nganda GW; Burns CC; Wassilak SG; Vertefeuille JF
    MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(32):878-82. PubMed ID: 26292207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Banda R; Korir C; Enemaku O; Corkum M; Usman S; Davis LB; Nganda Gw; Burns CC; Mahoney F; Vertefeuille JF;
    MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(46):1059-63. PubMed ID: 25412063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learnt from implementing community engagement interventions in mobile hard-to-reach (HTR) projects in Nigeria, 2014-2015.
    Hammanyero KI; Bawa S; Braka F; Bassey BE; Fatiregun A; Warigon C; Yehualashet YG; Tegene SG; Banda R; Korir C; Erbeto TB; Chukwuji M; Mkanda P; Adamu US; Nsubuga P
    BMC Public Health; 2018 Dec; 18(Suppl 4):1306. PubMed ID: 30541514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping circulatory vaccine-derived poliovirus in Kaduna state by scaling up special interventions in local government areas along rivers of interest- kamacha basin experience, 2013-2015.
    Musa AI; Shuaib F; Braka F; Mkanda P; Banda R; Korir C; Tegegne SG; Abdullahi S; Umeh GC; Nomhwange TI; Iyal HA; Ishaku S; Adamu U; Damisa E; Bagana M; Gugong V; Balarabe H; Nsubuga P; Vaz RG
    BMC Public Health; 2018 Dec; 18(Suppl 4):1303. PubMed ID: 30541497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria.
    Kalkowska DA; Franka R; Higgins J; Kovacs SD; Forbi JC; Wassilak SGF; Pallansch MA; Thompson KM
    Risk Anal; 2021 Feb; 41(2):289-302. PubMed ID: 32348621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.